The boss of Moderna, Stephane Bancel, tells us about how MRNA technology could transform the treatment of cancer. But will the personalised treatment plans it could create only be available in richer nations? Our global health correspondent, Naomi Grimley, provides analysis. Also this week we hear more from the exhibitors at the CES tech show. Analyst Paolo Pescatore tells us what he thinks the event says about the state of global tech. And the founder of Cameo, which took off in the pandemic, on how businesses that thrived in lockdown can survive in the very different world we find ourselves in in 2023.(Image: Messenger RNA techobnology, two Strands of mRNA on abstract background illustration. Credit: Getty Images)
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Erich G. Anderer, Chief of the Division of Neurosurgery and Surgical Director of Perioperative Services at NYU Langone Hospital–Brooklyn
09 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Nolan Wessell, Assistant Professor and Well-being Co-Director, Department of Orthopedic Surgery, Division of Spine Surgery, University of Colorado School of Medicine
08 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-08-2025 1AM EST
08 Dec 2025
NPR News Now